ECONOMIC ANALYSIS OF ETANERCEPT AS CONTINUOUS OR PAUSED THERAPY IN MODERATE TO SEVERE PSORIASIS FROM A PUBLIC PERSPECTIVE IN VENEZUELA

被引：0
|
作者：
Fernandes, R. A. [1 ]
Takemoto, M. L. S. [1 ]
Amaral, L. M. [1 ]
Cruz, R. B. [1 ]
Mould, J. F. [2 ]
Rodriguez, J. C. [3 ]
机构：
[1] ANOVA Knowledge Translat, Rio De Janeiro, RJ, Brazil
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Caracas, Venezuela
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A251 / A252
页数：2
相关论文
共 50 条
  • [1] ECONOMIC ANALYSIS OF ETANERCEPT AS PAUSED THERAPY IN MODERATE TO SEVERE PSORIASIS FROM A PRIVATE PERSPECTIVE IN BRAZIL
    Fernandes, R. A.
    Takemoto, M. L. S.
    Amaral, L. M.
    Cruz, R. B.
    Mould, J. F.
    Fujii, R. K.
    Brandt, H.
    Almeida, G. R.
    Manfrin, D. F.
    VALUE IN HEALTH, 2012, 15 (04) : A251 - A251
  • [2] ECONOMIC ANALYSIS OF ETANERCEPT IN RHEUMATOID ARTHRITIS FROM A PUBLIC PERSPECTIVE IN VENEZUELA
    Fernandes, R. A.
    Boada, V
    Mould, J. F.
    VALUE IN HEALTH, 2011, 14 (07) : A308 - A308
  • [3] Etanercept therapy for moderate to severe plaque psoriasis with involvement of the scalp
    Bagel, Jerry
    Kricorian, Gregory
    Klekotka, Paul
    Tyring, Stephen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB150 - AB150
  • [4] Joint pain improvement in patients on etanercept therapy for moderate to severe psoriasis
    Tyring, Stephen
    Kricorian, Gregory
    Gordon, Kenneth
    Klekotka, Paul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB158 - AB158
  • [5] Low-dose etanercept therapy in moderate to severe psoriasis in Korean
    Na, Jung Im
    Kim, Jun Hyung
    Park, Kyoung Chan
    Youn, Sang Woong
    JOURNAL OF DERMATOLOGY, 2008, 35 (08): : 484 - 490
  • [6] Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study
    Dauden, E.
    Griffiths, C. E. M.
    Ortonne, J-P
    Kragballe, K.
    Molta, C. T.
    Robertson, D.
    Pedersen, R.
    Estojak, J.
    Boggs, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (12) : 1374 - 1382
  • [7] The effects of etanercept therapy on patient reported outcomes for patients with moderate to severe psoriasis
    Krueger, GG
    Woolley, JM
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P155 - P155
  • [8] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Villacorta, Reginald
    Hay, Joel W.
    Messali, Andrew
    PHARMACOECONOMICS, 2013, 31 (09) : 823 - 839
  • [9] Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States
    Reginald Villacorta
    Joel W. Hay
    Andrew Messali
    PharmacoEconomics, 2013, 31 : 823 - 839
  • [10] ECONOMIC ANALYSIS OF ETANERCEPT IN RHEUMATOID ARTHRITIS FROM A PUBLIC PERSPECTIVE IN COLOMBIA
    Fernandes, R. A.
    Tovar, D. A. B.
    Mould, J. F.
    VALUE IN HEALTH, 2011, 14 (07) : A308 - A309
12345